consolidate the view that the local increase in levels of index of ONOO [44] ) in porcine vein grafts (P. Gadsdon iNOS increases NO, which, together with increased and J.Y. Jeremy, unpublished observations). superoxide, leads to the generation of ONOO and other nitrated oxygen species [9] .
In animal models of neointima formation (arterial injury, 3. Evidence that NO inhibits VSMC proliferation vein grafts), where VSMC proliferation and migration are central events, NOS activity and NO release are also 3.1. Pharmacological studies in vitro markedly altered. After balloon injury, there is inevitable endothelial loss, which ipso facto results in the loss of Early studies demonstrated that NO donor agents, endothelial constitutive NOS (eNOS). Endothelial reincluding sodium nitroprusside (SNP), nitrosothiols, Sgrowth occurs rapidly [25] , although several studies have nitroso-N-acetylpenicillamine (SNAP) and 3-morindicated that the regrown endothelium in injured coronary pholinosydon imine (SIN-1) inhibit the proliferation of arteries is dysfunctional [26, 27] . This leads to agonistisolated rat and rabbit VSMCs in tissue culture [45] [46] [47] [48] . selective impairment of endothelium-dependent vasodilat-
The effective concentrations of NO donor agents were ation, which suggests a defect in receptor-effector couhigher than in studies of vasodilator action but occurred at pling. The loss of endothelial eNOS may be compensated similar intracellular cGMP levels [47] . Below 1 mM SINfor by increased iNOS expression [28] . In balloon-injured 1, cells remained viable, as judged by ATP concentrations, rat carotid arteries, iNOS expression is induced by interalthough additional effects of higher concentrations of leukin 1-b (IL-1b) [29] . Medial and neointimal VSMCs SIN-1 on proliferation were accompanied by loss of cell are the main cell type expressing iNOS [30] .
viability [48] . Not all preparations of VSMCs showed The situation is similar in vein grafts. For example, equal sensitivity to NO donors and 8-Br-cGMP. Indeed, Cross et al. [31, 32] and Ku et al. [33, 34] found that synthetic state, isolated rabbit smooth muscle cells were porcine vein graft rings, pre-contracted with noradrenaline, inhibited, whereas contractile cells interacting with their failed to show endothelium-dependent relaxation in renative extracellular matrix within aortic explants were sponse to acetylcholine or histamine. Impaired endorefractory [49] . On the other hand, human saphenous thelium-dependent relaxation was also demonstrated in VSMCs within organ cultures were inhibited, arguing that explanted human coronary vein grafts, with no response to the difference was not simply one of contractile versus acetylcholine but a significant relaxation to A23187 synthetic cells [50] . [35, 36] . Since acetylcholine operates via receptor-mediated
In several studies, the effects of low, but not higher, NO release and A23187 by receptor-independent mechaconcentrations of NO-donors were mimicked by 8-Brnisms, these data also suggest that while ecNOS may be cGMP [47] , indicating the involvement of cGMP-depenpreserved in human vein grafts, disruption may occur at dent protein kinase. However, NO can also directly inhibit some point upstream in the signalling pathway linked to the synthesis of RNA and proteins in VSMCs [51] . NO the receptor. Consistent with this, in porcine vein grafts, also directly inhibits mitochondrial respiration, which, in there is a marked reduction in cGMP formation in the turn, may influence growth [52] . Sarkar et al. [53, 54] medial and intimal regions, even though eNOS content and recently suggested multiple sites for the effect of the NO activity is actually increased [37, 38] .
donors, SNAP and S-nitroso-glutathione (SNOG) on the Haemodynamic forces, which are altered by atheroma cell cycle in rat aortic VSMCs. Individually, these elicited and as a consequence of restenosis and vein graft thickena 50% reduction in the fraction of cells in the S and ing, also exert a powerful influence on endothelial struc-G 1M phases and a corresponding increase in the G 2 1 ture and function. For example, high shear stress induces fraction, suggesting that NO inhibits S-phase entry of activation of signal transduction mechanisms, including VSMCs. Addition of both donors together, however, phosphoinositide (PI) turnover [39, 40] . Thus, although immediately blocked replication reversibly in the S-phase, there is rapid endothelial regrowth in recently implanted an effect that was not mimicked by exogenous cyclic GMP. vein grafts, its functional integrity may be compromised by These experiments implied that NO inhibition of VSMC the impact of arterial haemodynamic forces. Increased proliferation is associated with two distinct and reversible ecNOS may constitute an adaptive response to shear stress.
cell cycle arrests, an immediate cGMP-independent SThere also appears to be a marked increase in iNOS in phase block and a cGMP-dependent shift back from the vein-grafts [38] . Although a decrease in NO activity is G -S boundary to a quiescent G -like state [53, 54] .
1 0 associated with neointima formation [41] , increased NO The studies with lipid-soluble cGMP analogues imply formation in itself may be deleterious to vein grafts. For that NO inhibits VSMC proliferation by activating the example, there is increased accumulation and infiltration cGMP-dependent protein kinase (protein kinase G). Howinto vein grafts of leukocytes, including neutrophils ever, NO-induced elevation of cGMP in VSMCs can [42, 43] , which generate large amounts of superoxide, activate adenosine 39,59cyclic monophosphate (cAMP)-dethereby transforming NO into ONOO [44] . Indeed we have pendent protein kinase [55] , which also is a potent recently detected large amounts of nitrated tyrosine (an inhibitor of VSMC replication [47, [56] [57] [58] .
Time course of the effects of NO on proliferation
balloon-injured pig carotid arteries [30] . The effect may have been direct or through platelet inhibition because Most in vitro experiments have studied the effect of NO, SIN-1 inhibits both the adhesion of platelets and mural NO-donor drugs or cGMP analogues added initially to thrombus formation in balloon-injured pig arteries [75] . cells stimulated to enter the cell cycle from quiescence.
Few systematic pharmacological studies of the effects of However, a similar inhibitory effect is obtained when the NO on neointima formation have been carried out in man. addition of NO-donors or 8-Br-cGMP is delayed for 6 h However, in the ACCORD study, administration of the NO after growth-factor stimulation (Taylor and Newby, undonors, linsidomine and molsidomine, was associated with published observations, 1999). Hence, the most important a modest improvement in the long-term angiographic result site of action of NO and cGMP may not be on early signal after angioplasty but had no effect on clinical outcome transduction events but later in the G phase of the cell [76] . 1 cycle. Similar results have been observed in the case of cAMP-elevating agents and several other physiological 3.4. Gene transfer and transgenics inhibitors of VSMC proliferation, including transforming growth factor-b and interferon-g [11, 59] . This is not to say A number of studies have established that gene transfer that the effects on early signalling events are irrelevant of eNOS successfully influences endothelium-dependent and, indeed, they may have more important roles in the relaxation [77] [78] [79] . Kullo et al. [78] studied rabbit carotid induction of early response genes (for example, metalloparteries exposed to adenoviral vectors encoding eNOS roteinases).
(ADeNOS). Over-expression of eNOS resulted in diminished contractile responses as well as enhanced endo-3.3. Pharmacological studies in vivo thelium-dependent relaxations [78] . In another study, the same authors introduced adenoviral vectors encoding In vivo effects of substrates for NO synthase and NO eNOS into the periarterial sheath (adventitia) of carotid donors may not be mediated through direct inhibition of arteries, which enhanced endothelium-dependent relaxation VSMC proliferation but also through inhibition of platelet when assessed four days later [79] . Both luminal and and leukocyte activation. Both of these cells can play a adventitial delivery represents a convenient means of role in atherogenesis and neointima formation [6, 59] (see introducing gene vectors into blood vessels, which may be sections on platelets and leukocytes below). Conversely, useful clinically. inhibitors of NO formation, such as L-NAME (L-nitroGene transfer and transgenic models have provided the arginine-methyl ester) can induce leukocyte activation most persuasive evidence for a role of NO in moderating [60] .
VSMC proliferation [80] [81] [82] . For example, transfer of both Direct, long-term inhibition of NO formation promotes eNOS and neuronal NOS (nNOS) inhibits VSMC proliferatherosclerosis and neointima formation in the hyperation and neointima formation in balloon injury and veincholesterolaemic rabbit thoracic aorta [61] . However, this grafting models [83] [84] [85] [86] . Interestingly, adventitial expresobservation has recently been challenged [62] . Several sion of the recombinant eNOS gene restores NO prostudies have demonstrated that the oral administration of duction in arteries without endothelium [87] L-arginine or NO donors inhibit the in vivo proliferation of Over-expression of human ecNOS in syngeneic rat VSMCs in laboratory animals [63, 64] . Administration of arterial SMCs using a retrovirus, which were then seeded L-arginine (which, as a substrate, increases endogenous NO onto balloon-injured carotid arteries, inhibited neointimal formation) to hypercholesterolaemic rabbits augments vasformation by 37% and induced marked dilatation at two cular NO formation and reduces atheromatous lesions in weeks compared with vector alone [82] . Orally adminisrabbits [65] . Interestingly, dietary correction of hypertered N-v-nitro-L-arginine blocked these changes. Varenne cholesterolaemia in the rabbit also normalises increased et al. [88] investigated the effect of intramural injection of endothelial superoxide production and, hence, generation adenovirus carrying the eNOS cDNA on pig coronary of ONOO [66] . In cholesterolaemic rabbits, the administraarteries subjected to angioplasty. In eNOS-transfected tion of L-arginine reduces intimal thickening in iliac animals, neointimal thickness, lumenal area and % rearteries denuded of endothelium with a balloon catheter stenosis were all reduced compared to animals treated with [67] [68] [69] . Similar inhibitory effects of L-arginine adminiscontrol vector [88] . Mice display a hyperplastic response tration on intimal thickening were obtained in the rat of the arterial wall in response to external carotid artery arterial injury model [70] [71] [72] [73] [74] . Chronic inhibition of NO ligation [89] . Mice with targetted disruption of the eNOS formation with L-NAME in rats also caused a significant gene show a greater increase in wall thickness compared to 89. increase in the vessel wall-to-lumen ratio [74] and accelerwild-type mice ated neointima formation in hypercholesterolaemic rabbits Given the larger quantities of NO generated, it is not [41] .
clear if iNOS functions through the same mechanisms as Administration of the NO donor (SIN-1) inhibited eNOS to limit VSMC proliferation. Porcine arteries infec-VSMC proliferation but not final neointimal thickening in ted with human iNOS cDNA and subjected to balloon injury exhibited a threefold increase in total NO synthesis of the effect should reverse the inhibitory action of NO and and a 15-fold level of cGMP (despite only 1% transfer that a precise molecular mechanism for the action of NO efficiency) as well as reduced intimal thickness [90, 91] .
should be defined. The administration of a NOS inhibitor reversed these effects [90, 91] .
Effects on the signal transduction pathways
The effect of transfer of human iNOS cDNA was investigated in a rat aortic allograft transplantation model
To place the effects of NO on signal transduction into [92] . After 28 days, control allografts were found to have context, a brief and simplified overview of the principal intimal thickening despite significant increases in both intracellular signalling mechanisms involved in VSMC iNOS mRNA and protein. Inhibition of NO production proliferation is warranted. VSMC proliferation is promoted with iNOS inhibitor, however, further increased intimal by the concerted action of several distinct signal transducthickening by 57%. In this model, cyclosporine suppressed tion pathways (Fig. 1 ). These include phospholipase C 21 the expression of and promoted intimal thickening. Conisoforms (which link to Ca release from intracellular versely, transduction with iNOS cDNA using adenoviral stores and activation of protein kinase C) and the ras, vector inhibited completely the development of allograft Raf-1, MAP kinase cascade [95] [96] [97] . Ultimately, these atherosclerosis. These data suggest that early immunepathways lead to transcription of the nuclear transcription mediated upregulation in iNOS expression partially supfactors, c-fos and c-jun, by mechanisms involving prepresses allograft arteriosclerosis.
existing transduction factors, including the serum response In injured rat carotid arteries, transfer of the iNOS gene factor. C-fos and c-jun together constitute the activator initiated at the time of vascular injury prevented intimal protein-1 complex that binds to the promoter region of hyperplasia, a response reversed by the administration of many other early response genes. Coupling of tyrosine L-N-6-(1-iminoethyl)-lysine [93] . In the same study, but kinase receptors to the soluble tyrosine kinases, c-src, using a different animal model, human iNOS gene transfer c-yes and c-fyn [98] leads to induction of the c-myc to injured porcine arteries also reduced intimal hyperplasia transcription factor [99] . Increased transcription of the by 51.8% [93] .
c-myc oncogene is required for VSMC proliferation When hearts from wild-type mice were transplanted into [100, 101] . Agents such as angiotensin II, 5-hydroxysyngeneic recipient mice, there was increased luminal tryptamine and thrombin, which act through G-proteinstenosis and increased intimal / medial ratios [94] . Allolinked receptors, trigger the same pathways also, through grafts taken from iNOS knock-out recipients had increased less completely understood mechanisms [102, 103] . Inflamneointima formation compared to wild-type controls [94] . matory cytokines, including interleukin-1 (IL-1) and It was concluded that iNOS plays a protective role in the tumour necrosis factor-a (TNF-a) act through receptors development of arteriosclerosis in transplantation, suppresthat couple transiently with cytosolic serine kinases (janus sing neointimal VSMC accumulation [94] . kinases, JAKs), which, in turn, activate signal transducers and activators of transcription (Stats) [104] . Inflammatory cytokines also cause translocation of the 4. Mechanisms underlying the inhibitory effects of nuclear factor-kB transcription factor (NF-kB) to the NO on VSMC proliferation nucleus [105] . The events shown to be affected by NO / cGMP are circled in Fig. 1A and discussed below. The success of various mechanisms in explaining the These early events, within the first 6 h after the addition inhibitory effects of NO on proliferation can be judged of growth factor, promote transition of cells from quiescagainst a series of increasingly stringent criteria (Table 1) .
ence (defined as G ) into the G phase of the cell cycle. Stated briefly, these are that addition of NO should They prime cells for further progression through the cell produce the effect, other agents that produce the same cycle (see Fig. 1B ), which may then be sustained by other effect should also inhibit VSMC proliferation, antagonism growth factors, including epidermal growth factor (EGF) Table 1 Criteria for judging the significance of mechanisms proposed to mediate the action of NO on VSMC proliferation 1. Addition of NO at the time points and concentrations that inhibit proliferation regulates the mechanism in the appropriate direction (i.e. activation or inhibition). 2. Modulation of the same pathway in the same sense by other agents also causes inhibition of proliferation. 3. Modulation of the mechanism in the opposite sense using pharmacological or molecular biological methods antagonises the effects of NO. 4. The biochemical mechanisms (e.g. phosphorylation events) regulating the mechanism in response to NO are defined. 3 21 cycle in many cell types [115, 116] . A principal substrate and augmentation of store-dependent Ca channels 21 for the G cyclins is the retinoblastoma (pRb) tumour (SDCs) and second messenger-operated Ca channels 1 21 suppressor gene [116] , which, in its hypophosphorylated (SMOCs). In this context, Ca -channel blockers such as 21 form, suppresses S-phase progression. Cyclin-dependent nifedipine and verapamil, which prevent Ca entry via phosphorylation of pRb negates its action, allowing repliblockade of these channels, are potent inhibitors of VSMC cation to progress. The activity of the cdks is itself proliferation and migration [130] [131] [132] . As mentioned, regulated positively and negatively by phosphorylation at cAMP-dependent kinases, in particular PKAs, can be different sites [117, 118] . Indeed, the essential role of activated by cGMP [55] . In turn, PKA phosphorylates 21 21 21 c-myc, in cell cycle progression may be explained by its Ca -Mg ATPases (Ca pumps) at both the plasma ability to induce the cdc25A protein phosphatase, which membrane and the sarcoplasmic reticulum, which results in 21 dephosphorylates and activates cdks99. Several cdk incytosolic Ca being pumped out of the cell or being hibitors, which are either selective for D cyclins (INK1-4) re-sequestered back into the sarcoplasmic reticulum [56] .
In VSMCs, SNAP decreased cytosolic Ca levels and or nonselective for D and E cyclins (p27 , p21
), play elicited phosphotyrosine dephosphorylation [133] . These an additional important role in regulating cdk phosphoryla- 21 effects are mimicked by the extra-and intracellular Ca tion of pRb [118, 119] . In principle, NO / cGMP could 21 chelators EGTA and BAPTA and by the Ca channel interfere at any stage of this signal transduction cascade, blocker [133] . Both BAPTA and nifedipine also decreased although the events for which there is direct evidence (see DNA synthesis [133] , providing further evidence to link below) are circled in Fig. 1B . 21 21 membrane Ca channels, Ca levels and dephosphorylation to the control of mitogenesis [133] . In contrast,
Calcium
Assender et al. [47] found no effect on basal or agonist-21 stimulated intracellular Ca by NO and 8-Br-cGMP at 21 There is no doubt that Ca plays a key role in vascular concentrations that inhibited VSMC proliferation (failed contraction and that the NO-cGMP axis mediates its criterion 1 of Table 1 ). 21 vasodilator effects in part by inhibiting Ca entry and Overall, the preceding studies provide strong evidence mobilisation [120] . Circumstantial evidence points to a that NO inhibits VSMC proliferation by preventing an 21 21 similar regulatory role of Ca in VSMC proliferation increase in cytosolic Ca . However, the precise relation-21 [121] . Vasoconstrictor agonists and growth factors generalship between NO, Ca mobilisation and VSMC proliferly cause an immediate (within seconds to minutes) increase ation remains to be fully elucidated, particularly in light of 21 21 in cytosolic Ca . Recent studies with thapsigargin, a the studies that showed no effect of NO on Ca . potent and selective inhibitor of the endoplasmic reticulum 21 Ca -sequestering ATPase, demonstrate the crucial role of 21 Ca stores in VSMC replication [122] [123] [124] . In isolated 4.3. MAP kinase human VSMCs, thapsigargin, at concentrations less than 10 21 nM, inhibited the release of Ca from intracellular pools A recent study by Yu et al. [134] demonstrated that [122] [123] [124] , although it did not acutely alter resting cytosodium, 8-bromo cGMP as well as a phosphodiesterase 21 solic Ca [122] [123] [124] . This highlights the importance of type V inhibitor (which elevates cGMP levels through release from intracellular stores, which may include the inhibition of its hydrolysis) all attenuate growth factorendoplasmic reticulum and the nuclear envelope [125] .
stimulated VSMC replication via a cGMP-dependent With regard to the NO-cGMP axis, NO has been shown mechanism. It was also demonstrated that sodium nitroin intact vascular preparations to inhibit agonist-induced prusside and 8-Br-cGMP decreased the activity of MAP 21 Ca mobilisation [126] . In turn, cyclic GMP influences kinase, MAP kinase kinase and their regulatory proteins Ras and Raf-1, which couple peptide growth factors to the cell proliferation may contribute to decreasing the extent of MAP kinase cascade [134] (criterion 1 of Table 1 ). SNAP hyperplasia [142] . Furthermore, indirect effects on other inhibited VSMC proliferation and increased protein cell types, such as endothelial cells, which generally tyrosine phosphatase activity, in particular, in proteins of suppress VSMC proliferation [143, 144] and macrophages, 70-85 kDa and |215 kDa molecular mass [135] . SNAP which are stimulatory [145] , can also influence the final also increased protein tyrosine phosphatase (PTPase) acresponse. tivity in VSMC homogenates, indicating that phosphotyrosine dephosphorylation was likely to be the result of increased PTPase activity. 8Br-cGMP and atrial nat-5.1. Effects on VSMC death riuretic peptide elicited similar effects [135] (criterion 2 of Table 1 ).
Cell death and apoptosis are prominent features of advanced atherosclerotic lesions, often resulting in the formation of hypocellular fibrous zones and a lipid-rich 4.4. c-myc necrotic core [146] [147] [148] . Apoptosis also occurs in restenotic lesions after balloon angioplasty [149, 150] . The Bennett et al. [136, 137] observed that 8-Br-cGMP, as main significance of VSMC apoptosis is to counteract the well as 8-Br-cGMP, heparin and interferon-g, at conincrease in neointimal cell number resulting from neointicentrations that caused a similar 50% inhibition of rat mal migration and proliferation. Apoptosis is generally aortic VSMC proliferation, all inhibited the expression of held to be silent, i.e., it does not result in growth-factor c-myc (criterion 1 of Table 1 ). Studies with antisense release or provoke an inflammatory response. Unlike oligonucleotides directed against c-myc demonstrate that necrosis, it therefore should not provoke compensatory this inhibition is sufficient to cause cell cycle arrest VSMC proliferation or migration nor induce iNOS in (criterion 2 of Table 1 ). Moreover, when c-myc was neighbouring cells. However, recent evidence suggests that over-expressed using a retroviral construct, the inhibitory bFGF can be released from cells dying by apoptosis and effects 8-Br-cGMP and the other agents was completely could therefore elicit proliferation in remaining healthy reversed (criterion 3 of Table 1 ) [136, 137] . Taken together, cells [151] . This might explain why the early occurrence of these data represent a strong case for considering c-myc, apoptosis [152] is strongly correlated with later hyperplasia which is active late in the late G phase of the cell cycle, iNOS also induces macrophage apoptosis [154, 155] , of these aforementioned cytosolic events. Ishida et al.
which, in turn, may influence VSMC proliferation. [138] have demonstrated that the NO donor, SNAP,
induces cyclin-dependent kinase inhibitor p21 . (criterion 1 of Table 1 ). Thus, NO ultimately inhibits the 5.2. VSMC migration and matrix deposition G / S transition by inhibiting Cdk2-mediated phosphoryla-1 tion of the retinoblastoma protein, and p21 induction is It is the currently held consensus that neointima formainvolved in the Cdk2 inhibition. tion after arterial injury or vein graft surgery involves Less effort has been devoted to identifying the cGMPmigration of medial VSMCs towards the lumen where they independent effects of NO on VSMC proliferation. NO continue to proliferate and secrete matrix proteins [11] . also exerts direct effects on ribonucleotide reductase, an
The mechanisms underlying migration have been reviewed enzyme essential in DNA synthesis [139] [140] [141] . Inhibition [156, 157] . There is much less data concerning the effects of this enzyme by NO (criterion 1 of Table 1 ) may result of NO and its derivatives on VSMC migration or matrix in cell cycle arrest at the G -S boundary 1 formation than proliferation. However, NO has been shown to inhibit VSMC migration when stimulated with angiotensin II through a cGMP-dependent mechanism [158] . NO modulates basal and endothelin-induced in-5. Indirect influences of NO on VSMC proliferation creases in collagen levels [159] , NO down-regulates the synthesis of type IV collagen and fibronectin but stimulates In a complex event, such as atherosclerosis or restenosis the production of laminin by rat mesangial cells [160] . In a after angioplasty, both cell death and direct inhibition of study in which porcine coronary EC and VSMCs were play [172] . VEGF augments NO release from the quiescent grown in co-culture, NO produced by the endothelium rabbit and human vascular endothelium [173] and induces inhibited VSMC production of collagen types I and III but NO-dependent relaxation in coronary arteries [174] . It has had no effect on collagen type I [161] . These effects were also been demonstrated that NO mediates VEGF-stimublocked by L-NAME. As noted previously, proliferating lated mitogenesis of microvascular ECs [175] . VEGFVSMCs in intact vascular tissues secrete metalloproteinstimulated NO release from simian virus 40 immortalised ases, which proteolyse matrix proteins, thereby allowing microvascular ECs induced cell migration whereas Lthem to migrate [11] . Trachtman et al. [160] have found NAME or antisense oligonucleotides to ecNOS suppressed that NO stimulates the activity of a 72-kDa neutral matrix this effect of VEGF [176] . In an in vivo model of metalloproteinase (gelatinase) in cultured rat mesangial angiogenesis, the rabbit cornea, Ziche et al. [177] found cells. If also true for VSMCs, this would constitute a that sodium nitroprusside potentiated the pro-angiogenic pathway by which NO might promote migration.
effect of substance P. The same authors found that angiogenesis stimulated by basic fibroblast growth factor 5.3. Effects on endothelial proliferation and death (bFGF) was unaffected by inhibitors of NO formation [177, 178] . This indicates that NO is one, but not the only, Intact endothelium is a key inhibitor of VSMC proliferfactor controlling angiogenesis in this system. Angiogenation [162, 163] . It follows that regeneration of damaged esis in the rabbit cornea in vivo and in vitro and migration endothelium is a major determinant of VSMC hyperplasia of human umbilical ECs is greatly reduced by the absence after balloon injury. In other circumstances, activated ECs of L-arginine [179] . VEGF transfer reduces intimal thickenare a source of VSMC mitogens [162, 163] .
ing via increased production of NO in carotid arteries Hansson et al. [164] demonstrated that ecNOS is rapidly [180] . upregulated in the ECs of vessels in response to injury. There is also a three-to sixfold increase in ecNOS protein 5.4. Effects on blood platelets and inflammatory cells and ecNOS mRNA in growing compared to growth-arrested bovine endothelial cells [164] . The increased release NO donors may also influence VMSC behaviour inof NO may limit neointima formation under the repairing directly through actions on platelets and leukocytes. It is EC. On the other hand, Kourembanas et al. [165] demonwell established that NO inhibits platelet and leukocyte strated that in vitro suppression of NO formation with adhesion to ECs [180] [181] [182] . On adhesion and aggregation, L-NAME caused a threefold increase in endothelin-1 (ETplatelets generate a number of pro-mitogenic substances, 1) and PDGF-B expression in human umbilical vein ECs.
including PDGF, TGF-b, epidermal growth factor (EGF), Both ET-1 and PDGF-B are potent promoters of VSMC thromboxane A (TXA ), 5-HT, platelet-activating factor 2 2 proliferation and are chemoattractants for VSMCs , platelet factor IV, fibrinogen, fibronectin, vWf, 168]. Similarly, long-term blockade of NO synthesis in rats thrombospondin and b-thromboglobulin, as well as resulted in increased tissue angiotensin converting enzyme heparitinase, elastase, collagenases and cathepsins activity and angiotensin II formation, an established [183, 184] . Neutrophils, T lymphocytes and monocytes mitogen for VSMCs [169] . Thus, suppression of NO release an array of substances that may also contribute to formation can increase VSMC proliferation either directly neointima formation, including peptide growth factors, or through modulation of other growth promoters.
leukotrienes (LTs), interleukins, histamine, TNF-a and With regard to EC regeneration itself, data are ambival-PAF. There is increasing evidence that there is significant ent. Neither NOS inhibitors nor superoxide dismutase 'cross talk' between platelets and incoming leukocytes. For (SOD) affect EC proliferation in culture [170] . Similarly, example, platelet-neutrophil complexes play a key role in vascular iNOS gene transfer, while inhibiting SMC prolifangina [185, 186] . Neutrophils, in addition to platelets, are eration, does not affect EC proliferation or viability [171] .
the main constituents of intracoronary thrombus in acute In relation to programmed EC death, the addition of NO myocardial ischaemia. In turn, microthrombi, which acactually inhibits lipopolysaccharide-induced apoptosis in cumulate secondarily to platelet adhesion, have been ECs by reducing caspase 3-like protease activity [171] . In suggested as being more relevant as a trigger to neointima a blood vessel, more rapid endothelial regrowth as a result formation than platelet accumulation alone. of NO-mediated protection from apoptosis would indirectly inhibit VSMC proliferation (see below).
5.5. Interactions of NO with reactive oxygen species, In contrast, there is compelling evidence for a key role lipoproteins and homocysteine may directly or indirectly for NO in angiogenesis, a process that quintessentially influence its effects on VSMC proliferation involves the proliferation, migration and tube formation of ECs [172] [173] [174] [175] . Angiogenesis is regulated predominantly It is by virtue of its interactions with reactive oxygen by vascular endothelial growth factor (VEGF), although species generated by 'oxidative stress' that NO can bemany other growth and humoral factors also come into come pro-atherogenic [187] . Briefly, NO reacts with superoxide (O ), hydroxyl (OH), peroxyl, alkoxyl, hyaccumulation of insoluble collagen [205] [206] [207] . Such ob-2 droperoxyl and hydrogen peroxide (H O ) as well as with servations are consistent with a role for homocysteine in 2 2 thiols [8] . Principal amongst the products of these rethe pathogenesis of atherosclerosis. In the majority of these 2 actions are peroxynitrite (ONOO) nitrite (NO ), nitrate in vitro studies, high concentrations of homocysteine (mM) 2 2 (NO ), nitrosonium ions and nitroxide ions [187] . In the were used to elicit effects. Since homocysteine levels 3 presence of transition elements (e.g. copper or iron), NO become pathological in the 20-100 mM range, these data can also undergo reactions with phenolics, thiols and indicate that, in vivo, homocysteine interacts with other secondary amines to yield nitrosothiols and iron nitrosubstances to promote angiopathy. For example, oxidation tyrosyls [187] . Nitrosothiols act as naturally occurring NO of homocysteine can promote the formation of H O and 2 2 2 donors. Indeed, the formation of S-nitrosothiols may O , [208] which augment VSMC proliferation but impair 2 account for the ability of ONOO to produce vascular EC growth and function [193, 194] . We have recently relaxation [188] . Nitrosothiols also inhibit VSMC proliferestablished that copper markedly augments the inhibitory ation. At a mechanistic level, ONOO is ambivalent in that effect of homocysteine on endothelium-dependent relaxait can elicit events that are either pro-or anti-mitogenic.
tion of the isolated rat aorta, an effect that is reversed by 21 For example, ONOO elicits release of [Ca ] in VSMCs the presence of superoxide dismutase and catalase i 21 2
but reduces IP -mediated release of Ca in response to [193, 194] . We proposed that O generated by homo- mimicked by ONOO [190] . Although ONOO activates angiopathic impact of homocysteine. guanylate cyclase, it is 50-100 times less potent than NO [191] . Interestingly, acidic FGF enhances ONOO-induced apoptosis in primary murine fibroblasts [192] .
In the context of ONOO, we have recently explored the 6. Concluding remarks pro-atherogenic effect of homocysteine, an established risk factor for accelerated atherosclerosis [193, 194] .
Although it is clear from current evidence that NO plays Homocysteinaemia in animal models results in endothelial a key role in mediating vascular remodelling, its mechadenudation, VSMC proliferation, matrix protein deposition nisms of action are far from being straightforward. For and intimal thickening [195] [196] [197] [198] . Homocysteine inhibits example, NO elicits diametrically opposite effects on EC growth in culture [199] [200] [201] but promotes proliferation different cell types: namely, the inhibition of VSMC of VSMCs [202] [203] [204] . In addition, homocysteine enhances proliferation but the promotion of EC proliferation and VSMC collagen matrix production and an excessive microvessel formation. This selectivity is remarkable given 
